The circular RNA landscape: Biogenesis, functions, identification pipelines, and biomedical applications

dc.contributor.authorAbu Obaid, Asmaa
dc.contributor.authorErrafii, Khaoula
dc.contributor.authorHamdi, Salsabil
dc.contributor.authorETAL..
dc.date.accessioned2026-07-02T07:56:22Z
dc.date.available2026-07-02T07:56:22Z
dc.date.issued2026
dc.descriptionCircular RNAs (circRNAs) were first observed in plant viroids in 1976 [1]. In 1979, they were identified in human HeLa cells through electron microscope analysis confirming their circular form. However, initially they were considered non-functional [2,3]. With the advent of comprehensive RNA sequencing (RNA-seq) and computational pipelines, research into circRNAs has uncovered pervasive circRNA expression across metazoans [4]. For example, Jeck et al., 2014 identified that 14 % of transcribed genes in human fibroblasts produce circular RNAs [5].
dc.description.abstractCircular RNAs (circRNAs), a subtype of RNA molecules, possess distinctive characteristics, including their closed circular structure, stability, tissue specificity and long half-life compared to their linear counterparts. Initially presumed to be non-functional byproducts of splicing, advances in RNA-seq and bioinformatics have revealed the existence of these RNAs and begun to clarify their functions. Insight into their diverse functions revealed their roles, including regulating various cellular processes such as gene expression, transcription, translation into proteins (e.g., cap-independent translation), binding to microRNAs (miRNAs), and interacting with proteins. Moreover, mitochondria-encoded circular RNAs (mecciRNAs) have emerged as a novel subclass of circRNAs. Notably circRNAs have been associated with the development or progression of diseases (e.g., cancer, cardiometabolic and neurodegenerative disorders), highlighting diagnostic and therapeutic potential. In our review, we aim to summarize the current knowledge on circRNAs, covering their biogenesis, functions, identification tools, and potential biomedical applications. Keywords: Back-splicing, Biomarker,ceRNA, Circular RNA, Liquid biopsy, m6A, RNA-Binding proteins
dc.identifier.citationBaiddou, C., Knidiri, M., Ghazi, B., Obaid, A. A., Hamdi, S., & Errafii, K. (2026). The circular RNA landscape: Biogenesis, functions, identification pipelines, and biomedical applications. Non-coding RNA Research, 18, 39-51.
dc.identifier.doihttps://doi.org/10.1016/j.ncrna.2025.12.005
dc.identifier.urihttps://repository.adu.ac.ae/handle/1/8330
dc.language.isoen
dc.publisherKeAi Communications Co.
dc.titleThe circular RNA landscape: Biogenesis, functions, identification pipelines, and biomedical applications
dc.typeOther

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
DOI for fulltext access.docx
Size:
22.76 KB
Format:
Microsoft Word XML

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections